How to Select the Right Cost-Effectiveness Model? A Systematic Review and Stepwise Approach for Transferring an Existing Health Economic Model for Rheumatoid Arthritis

H.G.M. van Haalen; A. Tran-Duy; A. Boonen; J.L. Severens

doi:10.1016/j.jval.2013.08.1639

How to Select the Right Cost-Effectiveness Model? A Systematic Review and Stepwise Approach for Transferring an Existing Health Economic Model for Rheumatoid Arthritis

Value in Health ◽

10.1016/j.jval.2013.08.1639 ◽

2013 ◽

Vol 16 (7) ◽

pp. A590

Author(s):

H.G.M. van Haalen ◽

A. Tran-Duy ◽

A. Boonen ◽

J.L. Severens

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Health Economic ◽

Cost Effectiveness ◽

Economic Model ◽

Stepwise Approach ◽

Effectiveness Model ◽

Health Economic Model ◽

The Right

Download Full-text

A health economic model to assess the cost-effectiveness of OPTIFAST for the treatment of obesity in the United States

Journal of Medical Economics ◽

10.1080/13696998.2018.1468334 ◽

2018 ◽

Vol 21 (9) ◽

pp. 835-844 ◽

Cited By ~ 2

Author(s):

Mark Nuijten ◽

Agnieszka Marczewska ◽

Krysmaru Araujo Torres ◽

Bahareh Rasouli ◽

Moreno Perugini

Keyword(s):

United States ◽

Health Economic ◽

Cost Effectiveness ◽

Economic Model ◽

The United States ◽

Health Economic Model ◽

Treatment Of Obesity ◽

The Cost

Download Full-text

A health economic model to assess the cost-effectiveness of PEG IFN ?-2a and ribavirin in patients with mild chronic hepatitis C

Journal of Viral Hepatitis ◽

10.1111/j.1365-2893.2006.00831.x ◽

2007 ◽

Vol 14 (8) ◽

pp. 523-536 ◽

Cited By ~ 8

Author(s):

S. Gerkens ◽

M. Nechelput ◽

L. Annemans ◽

B. Peraux ◽

M. Mouchart ◽

...

Keyword(s):

Health Economic ◽

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Economic Model ◽

Health Economic Model ◽

The Cost

Download Full-text

Cost-Effectiveness of Switching Patients with Type 2 Diabetes from Insulin Glargine to Insulin Detemir in Chinese Setting: A Health Economic Model Based on the PREDICTIVE Study

Value in Health ◽

10.1016/j.jval.2011.11.018 ◽

2012 ◽

Vol 15 (1) ◽

pp. S56-S59 ◽

Cited By ~ 18

Author(s):

Li Yang ◽

Torsten Christensen ◽

Fengyu Sun ◽

Jinghua Chang

Keyword(s):

Type 2 Diabetes ◽

Health Economic ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Economic Model ◽

Insulin Detemir ◽

Model Based ◽

Health Economic Model ◽

Predictive Study

Download Full-text

PIN19 A COST-EFFECTIVENESS ANALYSIS OF A PROPHYLACTIC CERVICAL CANCERVACCINE IN GERMANY: RESULTS FROM A HEALTH ECONOMIC MODEL

Value in Health ◽

10.1016/s1098-3015(10)65526-x ◽

2007 ◽

Vol 10 (6) ◽

pp. A441 ◽

Cited By ~ 1

Author(s):

T Hammerschmidt ◽

U Siebert ◽

TF Schwarz ◽

A Schneider ◽

RM Rogoza ◽

...

Keyword(s):

Health Economic ◽

Cost Effectiveness ◽

Economic Model ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Health Economic Model

Download Full-text

The Sheffield rheumatoid arthritis health economic model

Rheumatology ◽

10.1093/rheumatology/ker243 ◽

2011 ◽

Vol 50 (suppl 4) ◽

pp. iv26-iv31 ◽

Cited By ~ 15

Author(s):

J. Tosh ◽

A. Brennan ◽

A. Wailoo ◽

N. Bansback

Keyword(s):

Rheumatoid Arthritis ◽

Health Economic ◽

Economic Model ◽

Health Economic Model

Download Full-text

PDB8 COST-EFFECTIVENESS OF SWITCHING PATIENTS EITH TYPE 2 DIABETES FROM INSULIN GLARGINE TO INSULIN DETEMIR IN A CHINESE SETTING: A HEALTH ECONOMIC MODEL BASED ON THE PREDICTIVE STUDY

Value in Health ◽

10.1016/s1098-3015(11)73183-7 ◽

2010 ◽

Vol 13 (7) ◽

pp. A527

Author(s):

L Yang ◽

T Christensen ◽

F Sun ◽

J Chang

Keyword(s):

Type 2 Diabetes ◽

Health Economic ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Economic Model ◽

Insulin Detemir ◽

Model Based ◽

Health Economic Model ◽

Predictive Study

Download Full-text

CE1 COST-EFFECTIVENESS OF SWITCHING PATIENTS WITH TYPE 2 DIABETES FROM INSULIN GLARGINE TO INSULIN DETEMIR IN A CHINESE SETTING: A HEALTH ECONOMIC MODEL BASED ON THE PREDICTIVE STUDY

Value in Health ◽

10.1016/s1098-3015(10)72005-2 ◽

2010 ◽

Vol 13 (3) ◽

pp. A5

Author(s):

L Yang ◽

T Christensen ◽

J White ◽

F Sun

Keyword(s):

Type 2 Diabetes ◽

Health Economic ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Economic Model ◽

Insulin Detemir ◽

Model Based ◽

Health Economic Model ◽

Predictive Study

Download Full-text

A Comparison of the Cost-Effectiveness of In Vitro Fertilization Strategies and Stimulated Intrauterine Insemination in a Canadian Health Economic Model

Journal of Obstetrics and Gynaecology Canada ◽

10.1016/s1701-2163(16)32826-2 ◽

2008 ◽

Vol 30 (5) ◽

pp. 411-420 ◽

Cited By ~ 9

Author(s):

Taimur Bhatti ◽

Akerke Baibergenova

Keyword(s):

Health Economic ◽

Cost Effectiveness ◽

In Vitro Fertilization ◽

Economic Model ◽

Intrauterine Insemination ◽

Vitro Fertilization ◽

Canadian Health ◽

Health Economic Model ◽

The Cost

Download Full-text

Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model

Eye ◽

10.1038/sj.eye.6702964 ◽

2007 ◽

Vol 23 (1) ◽

pp. 132-140 ◽

Cited By ~ 16

Author(s):

W C Stewart ◽

J A Stewart ◽

M A Mychaskiw

Keyword(s):

Health Economic ◽

United Kingdom ◽

Cost Effectiveness ◽

Economic Model ◽

Timolol Maleate ◽

The United Kingdom ◽

Health Economic Model

Download Full-text

An In Silico Health Economic Model Applied to Cryopyrin Associated Periodic Syndromes (Caps): Cost Effectiveness of Prevention Effects of Ultra-Orphan Drugs for Rare Diseases

Value in Health ◽

10.1016/j.jval.2015.09.2444 ◽

2015 ◽

Vol 18 (7) ◽

pp. A669

Author(s):

L Trieste ◽

O Della Casa Alberighi ◽

L Accame ◽

V Lorenzoni ◽

J Frenkel ◽

...

Keyword(s):

Health Economic ◽

Cost Effectiveness ◽

Rare Diseases ◽

Economic Model ◽

In Silico ◽

Orphan Drugs ◽

Health Economic Model

Download Full-text